Trials / Completed
CompletedNCT00092963
Study to Test an Approved Product in the Early Treatment of Migraine (0462-065)
A Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled Study to Examine the Efficacy of Rizatriptan 10 mg Tablet Administered Early During a Migraine Attack While the Pain is Mild
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 529 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to test the effectiveness of an approved drug in the early treatment of migraine while the pain is still mild.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0462, rizatriptan benzoate / Duration of Treatment: 1day | |
| DRUG | Comparator: placebo / Duration of Treatment: 1 day |
Timeline
- Start date
- 2004-08-17
- Primary completion
- 2005-01-14
- Completion
- 2005-01-14
- First posted
- 2004-09-29
- Last updated
- 2024-08-14
Source: ClinicalTrials.gov record NCT00092963. Inclusion in this directory is not an endorsement.